Skip to content

HoLEP vs BPRP of a Large Volume BPH: a Randomised Controlled Trial

Holmium Laser Enucleation vs Bipolar Resection of a Large Volume BPH: a Randomised Controlled Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04143399
Enrollment
145
Registered
2019-10-29
Start date
2016-02-14
Completion date
2019-06-10
Last updated
2019-10-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

BPH With Urinary Obstruction, Male

Keywords

BPH, enucleation, Large Prostate, LUTS, IPSS, quality of life

Brief summary

To compare bipolar resection versus holmium laser enucleation for management of large BPH.

Detailed description

To compare safety and efficacy of bipolar resection (BPRP) versus holmium laser enucleation (HoLEP) for management of large BPH (\> 75 gm).

Interventions

cystoscopic transurethral enucleation of the prostate using Holmium laser (Versa pulse 100W; Lumenis; Germany)

cystoscopic transurethral resection of the prostate using bipolar energy

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
MALE
Age
45 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients suffering from LUTS secondary to infravesical obstruction from BPH * failed medical treatment * International Prostate Symptom Score (IPSS) \> 13 * a peak urinary flow rate (Qmax) \< 15 ml/sec * a prostate size ≥ 75 gm

Exclusion criteria

* presence of a urethral stricture * neurological disorder * bladder cancer * prostate cancer * previous history of bladder neck surgery or TURP

Design outcomes

Primary

MeasureTime frameDescription
hemoglobin drop postoperatively (gm/dL)Immediate postoperativelydifference in hemoglobin concentration postoperatively vs preoperatively
operative duration in minutesduring surgeryoperative duration
Hospital stay in daysimmediately after surgeryHospital stay

Secondary

MeasureTime frameDescription
International prostate symptom score (IPSS)Two yearsan international commonly used score ranging from 0 - 35 (the worst is 35) evaluating voiding and storage urinary symptoms using 7 questions each one is scored from 0 to 5 according to severity of symptom
complications (%)Two yearsintraoperative and postoperative complications including blood transfusion, capsular perforation, irritative symptoms, SUI, urethral stricture, bladder neck contracture, urinary retention.
Catheter durationimmediate postoperativelyCatheter duration in hours
Quality of life (QoL)Two yearssection of International prostate symptom score (IPSS) one question scored from 0 up to 6 (6 is worst)
urine flowTwo yearsQmax (ml/s),
post-voiding residual urineTwo yearspostvoiding residual urine (ml)

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 17, 2026